Jones James bought CPIX
November 5, 2025 · Form 4 insider transaction
Jones James bought 13 shares of Cumberland Pharmaceuticals Inc. at $2.53 per share, a transaction worth $32.89. The trade was recorded as l under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 26 days after the transaction.
Direction
Acquired (buy-side)
Shares
13
Price
$2.53
Total value
$32.89
InsiderJones James
Role—
SecurityCommon Stock
Transaction codeL: L
Transaction dateNovember 5, 2025
Filing dateDecember 1, 2025
Shares owned after44,530
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024.